STAT Plus Novartis and Amgen filed competing lawsuits over a potentially lucrative deal to jointly develop and market Aimovig a new migraine treatment. httpsbuff.ly2UjSFR1Â
STAT Plus: Novartis and Amgen filed competing lawsuits over a potentially lucrative deal to jointly develop and market Aimovig, a new migraine treatment. https://buff.ly/2UjSFR1
19:00 EDT 4 Apr 2019 |
STAT
More From BioPortfolio on "STAT Plus: Novartis and Amgen filed competing lawsuits over a potentially lucrative deal to jointly develop and market Aimovig, a new migraine treatment. https://buff.ly/2UjSFR1 "